Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study. (Q46013425)
Jump to navigation
Jump to search
scientific article published on 14 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study. |
scientific article published on 14 December 2012 |
Statements
1 reference
Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study. (English)
1 reference
T Ostenfeld
1 reference
A Krishen
1 reference
R Y Lai
1 reference
J Bullman
1 reference
A J Baines
1 reference
J Green
1 reference
P Anand
1 reference
M Kelly
1 reference
14 December 2012
1 reference
17
1 reference
6
1 reference
844-857
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference